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The phenobarbital-inducible form of cytochrome P-450 purified from rabbit liver microsomes is phosphor- 
ylated by CAMP-dependent protein kinase at a single site, the serine residue in position 128 of the amino 
acid sequence. The serine is located in a characteristic recognition sequence for CAMP-dependent protein 
kinase and is part of a primary structure which is conserved during evolution, present also in phenobarbital- 
inducible rat cytochrome and cytochrome P-450 CAM from Pseudomonas putida. The contribution of these 
findings to our understanding of the structure and membrane topology of cytochrome P-450 LM2 and its 
turnover regulated by phosphorylation is discussed. 
Cytochrome P-450 CAMP phosphokinase Protein phosphorylation 
1. INTRODUCTION the second messenger CAMP [5]. 
Protein phosphorylation is a regulatory princi- 
ple in control of many cellular processes [1,2]. 
Phosphorylation of the phenobarbital-inducible 
form of cytochrome P-450 LM2 purified from rab- 
bit liver microsomes in solution [3] and 
reconstituted membranes [4] by CAMP-dependent 
protein kinase was shown to decrease its enzymatic 
activity [4] by conversion into cytochrome P-420 
with consequent loss of heme [5]. Thus breakdown 
of P-450 and therefore its turnover may be under 
the control of adrenergic transmitters mediated by 
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Here we show that P-450 is phosphorylated at a 
single site, the serine residue in position 128 of the 
amino acid sequence. This serine is located in a 
partial sequence which is specific for substrates of 
CAMP-dependent protein kinase. These findings 
contribute to our understanding of the structure 
and membrane topology of P-450 and regulation 
of P-450 turnover. 
2. MATERIALS AND METHODS 
[T-~~P]ATP was purchased from Amersham, 
HPLC solvents from Baker, TPCK-trypsin from 
Merck, Darmstadt, and CM Sepharose Cl-6B 
from Pharmacia, Freiburg i.Br. Reagents used for 
high-performance liquid chromatography (HPLC) 
were all of spectroscopic or HPLC grade. All other 
chemicals were of the highest quality commercially 
available. 
Cytochrome P-450 LM2 was purified from liver 
microsomes of phenobarbital-treated rabbits by 
the method of Imai et al. [6]. These preparations 
had specific contents of 18-20 nmol/mg protein 
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and contained 0.2% Emulgen 913 and minute 
amounts of protein contaminants detectable by 
silver staining of their SDS electropherograms. 
The protein contaminants were removed before in- 
cubation by chromatography on a small aminooc- 
tyl Sepharose 4B column [6] equilibrated with 
10 mM potassium phosphate buffer (pH 7.3) con- 
taining 20% glycerol and 0.2% Emulgen 913, the 
detergent by subsequent chromatography on CM 
Sepharose Cl-6B. 
The catalytic subunit of CAMP-dependent pro- 
tein kinase was purified to homogeneity from 
bovine heart [7] to a specific activity of 3 units/mg. 
Phosphorylation was performed in 1 ml of 
50 mM Hepes buffer (pH 7.2) containing 1 mg 
cytochrome P-450, 70 ng catalytic subunit, 10 mM 
MgCL and 25 FM [Y-~~P]ATP (500 cpm/pmol) at 
30°C for 60 min. The reaction was stopped with 
TFA (final concentration 0.1070, v/v). The protein 
was separated from ATP by adsorbent filtration 
on a SEP-PAK Cr8 cartridge (Waters), eluted with 
0.1% TFA/70% acetonitrile and lyophilized. 
Purified and phosphorylated P-450 (5 mg) was 
cleaved by 0.1 mg TCPK-trypsin in 2 ml of 0.2 M 
ammonium bicarbonate (pH 8.3) at 37°C for 12 h, 
the reaction being stopped by adding 20~1 TFA. 
After lyophilisation the tryptic peptides were 
dissolved in 250 ~1 of 1% TFA containing 10% 
acetonitrile and separated by HPLC on a reversed 
phase C-18 wide-pore column (4.6 x 250 mm, pore 
size 300 A, Vydac RP-218) using a Waters HPLC 
system; the chromatographic onditions, including 
those for rechromatography, are described in 
detail in the legends to figs 1 and 2. For detection, 
the UV absorbance at 214 and 280 nm was 
measured and 32P radioactivity per fraction deter- 
mined in parallel. 
Rechromatographed pure peptides were sub- 
jected to amino acid analysis in a Durrum D-500 
amino acid analyser after hydrolysis of the dried 
sample in 600111 of 5.7 N HCl containing 0.5% 
phenol at 110°C for 24 h in evacuated tubes. 
Edman degradation for amino acid sequence 
determination was done with a Beckman liquid 
phase sequencer with a spinning-cup modification 
in the presence of polybrene 181. PTH derivatives 
were identified by HPLC and 32P radioactivity of 
the degraded residues was measured by liquid scin- 
tillation counting using a Packard liquid scintilla- 
tion counter. 
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3. RESULTS AND DISCUSSION 
Comparison of the peptide profile of a gradient 
elution HPL-chromatogram of a tryptic digest of 
P-450 phosphorylated by CAMP kinase and the 
profile of “P radioactivity (fig.1) shows that 
almost all radioactive phosphate appears in one 
peak. Rechromatography of this peak under 
isocratic conditions separates the radioactive pep- 
tide from other nonradioactive peptides (fig.2). 
The radioactive peptide consists of 1 alanine, 2 
arginines, 1 phenylalanine, 1 leucine, 1 methio- 
nine, 1 serine and 1 threonine as indicated by the 
amino acid analysis shown in table 1. 
The sequence of these amino acids determined 
by Edman degradation is identical with the se- 
quences of amino acids 126-133 of the known 
primary structure of rabbit cytochrome P-450 
LM2 [9] and of rat cytochrome P-450 e [lo], both 
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Fig.1. Gradient HPLC elution profile of the tryptic 
peptides of LM2 (1 mg injected) on a reversed phase 
C-18 column (4.6 x 250 mm, pore size 300 A, Vydac 
RP-218); solvent A, 0.1% TFA; solvent B, 0.1% 
TFA/29.9% water/70% acetonitrile; flow rate 
1.5 ml/min, 40°C. Upper panel: UV absorbance profile 
at 214 nm; the solid peak contains a radioactive tryptic 
peptide. The straight lines represent the gradient of 
solvent B in vol% (right ordinate scaling). Lower panel: 
32P radioactivity profile. 
Volume 187, number 1 FEBS LETTERS July 1985 
t [mbn]- 
Fig.2. HPL rechromatography of the radioactive peak 
of fig.1 on the same column under isocratic conditions 
(80% solvent A, 20% solvent B). For other conditions 
see fig.1. Upper panel: UV absorbance profile at 
214 nm, the filled peak contains the pure radioactive 
tryptic peptide. Lower panel: ‘*P radioactivity profile. 
isozymes inducible by phenobarbital (see fig.3). 
Furthermore, this is the only sequence in the 
primary structure of cytochrome P-450 LM2 which 
has the same amino acid composition as the 
radioactive peptide. Arg 126 is preceded by 
arginine and Arg 133 followed by aspartic acid. 
Both sequences are known cleavage sites for 
trypsin. 
The site of phosphorylation is Ser 128. The 
radioactivity of PTH-serine released by Edman 
degradation rose to a peak 12-times the 
background intensity with a tail due to carry-over 
of radioactivity to subsequent cycles (fig.4). 
Table 1 
Amino acid composition of the phosphorylated peptide 
separated from a tryptic digest of cytochrome P-450 
LM2 
Amino acid pm01 Residue 
Alanine 
Arginine 
Leucine 
Methionine 
Phenylalanine 
Serine 
Threonine 
495.1 1.13 (1) 
756.8 1.72 (2) 
546.2 1.24 (1) 
311.2 0.71 (1) 
456.0 1.04 (1) 
515.8 1.17 (1) 
439.1 1.00 (1) 
Fig.3. Comparison of the amino acid sequence of 
purified tryptic peptide (upper line), marked P* on 
serine for “P radioactivity, with published partial 
sequences of phenobarbital-induced cytochrome P-450 
from rat liver [lo] (middle line), and rabbit liver [9] 
(lower line). The rectangle induces the specific substrate 
sequence phosphorylated by CAMP-dependent protein 
kinase [12]. 
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Fig.4. “P radioactivity of the PTH-amino acids released 
by sequential Edman degradation cycles. 
The phosphorylation site is situated in a region 
of polar amino acids and close to the C-terminal 
end of one of the two regions of P-450 which are 
being discussed as part of the heme-binding site 
[9,11]. Both phosphorylation and heme reduction 
require access to these sites from the cytoplasm. 
That P-450 phosphorylation is observed in 
reconstituted membranes [4] is consistent with this 
requirement. 
Our data support the view that specific 
phosphorylation of cytochrome P-450 LM2 and its 
ensuing transformation to cytochrome P-420 [5] 
which is considered to be an irreversibly denatured 
form has physiological significance as hormone- 
dependent ‘down regulation’ of the cellular level of 
P-450. The sequence Arg-Arg-Phe-Ser which is 
recognized by CAMP kinase [12] is present in the 
primary structure of rabbit cytochrome P-450 
LM2 [9,13], rat cytochrome P-450 e [lo] and 
cytochrome P-450 CAM from Pseudomonas 
23 
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putida [14], but not in rabbit cytochrome P-450 
LM4 [ 151, rat cytochromes P-450 c and d [lo] and 
mouse cytochrome Ps-450 [16], the last 4 named 
being 3-methylcholanthrene-inducible isozymes. It 
is also absent in mitochondrial cytochrome P-450 
(SCC) from the bovine adrenal cortex [17]. Cor- 
respondingly, cytochrome P-450 LM4 was a poor 
substrate for CAMP kinase but a good substrate 
for protein kinase C prepared from rat brain (un- 
published). This raises two interesting questions: 
whether turnover of cytochromes P-450 generally 
is regulated by phosphorylation, and whether dif- 
ferent kinases regulate turnover of different 
cytochromes P-450. 
A minor aspect of our results relates to the 
unknown tertiary structure of P-450. The Ser 128 
should be located on the surface of the protein 
near to the heme binding site but not at the binding 
site of type I substrates - the degree of 
phosphorylation was not impeded by the presence 
of benzphetamine, a typical type I substrate, in 
saturating concentrations (not shown). The charge 
of the protein surface around Ser 128 appears to be 
critical for the conformation of cytochrome P-450, 
as phosphorylation of Ser 128 causes conforma- 
tional transition of P-450 to cytochrome P-420, 
which strongly affects the protein environment of 
the heme and results in drastic spectral changes 
and a propensity to lose heme [5]. 
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